Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Treatment of Acne in Women

Description

The presentation discusses the unique considerations in treating acne in women, noting that adult women experience acne more frequently than men and that hormonal factors significantly influence this condition. Various treatment options are explored, especially concerning hormonal contraceptives. Combined oral contraceptives (COCs) are highlighted as beneficial for acne, while progestin-only pills may worsen it due to their androgenic effects. The newly introduced drospirenone-only pill is mentioned, emphasizing its potential efficacy and safety despite ongoing concerns about venous thromboembolism (VTE). Furthermore, hormonal IUDs are associated with an increased risk of developing acne. For women who are pregnant or nursing, safe topical treatments such as azelaic acid and benzoyl peroxide are discussed, along with the need for caution regarding systemic medications. Key takeaways include the assertion that effective treatments are available for managing acne during pregnancy and breastfeeding, and the discussion also emphasizes the slow onset and sustained improvement in acne treatment with spironolactone compared to doxycycline. Overall, the session underlines the importance of individualized treatment plans for women suffering from acne, particularly in contexts influenced by hormonal changes.

View more

Conclusions

  • Acne is more prevalent in adult women than in men, which necessitates targeted treatments.
  • Hormonal factors, including the menstrual cycle, significantly impact acne, and all acne is influenced by hormones.
  • Oral contraceptives (OCPs) can improve acne, especially those combining estrogen and progestin, while progestin-only pills can worsen it.
  • The new drospirenone-only contraceptive pill has potential benefits for acne but requires further study due to safety concerns.
  • Hormonal IUDs are associated with a higher risk of developing acne compared to non-hormonal IUDs.
  • Acne treatment during pregnancy can be effectively managed with specific topical agents while avoiding harmful medications.
  • Spironolactone provides an effective acne treatment option for women, with a slower onset but higher effectiveness over time compared to doxycycline.
  • deBastos et al. Cochrane Database. Online pub March 2014. DOI:10.1002/14651858.CD010813.pub2.
  • Palacios S et al. Acta Obstet Gynecol Scand. 2019;98: 1549-1557.
  • Munjal A et al. JAAD 2022;87(5):1112-1114.
  • Ly S et al. Dermatol Ther 2023;13:115-130. https://doi.org/10.1007/s13555-022-00854-3
  • Pugashetti R, Shinkai K. Dermatologic Therapy 2013;26:302-311.
  • Schaefer C et al in Drugs During Pregnancy and Lactation 2007.
  • Dreno B et al. Acta Derm Venereol 2024;104:adv26002.
  • Auffret N et al. JEADV 2016;30(5):824-828.